159 related articles for article (PubMed ID: 7687170)
1. Serum profiles of insulin-like growth factors and their binding proteins in adults with growth hormone receptor deficiency treated with insulin-like growth factor I.
Fielder PJ; Gargosky SE; Vaccarello M; Wilson K; Cohen P; Diamond F; Guevara-Aguirre J; Rosenbloom AL; Rosenfeld RG
Acta Paediatr Suppl; 1993 Mar; 388():40-3; discussion 44. PubMed ID: 7687170
[TBL] [Abstract][Full Text] [Related]
2. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
3. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
[TBL] [Abstract][Full Text] [Related]
4. Regulation of serum insulin-like growth factors and their binding proteins in Ecuadorean patients with growth hormone receptor dysfunction (growth hormone insensitivity).
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Cohen P; Hintz RL; Rosenfeld RG
Acta Paediatr Scand Suppl; 1991; 377():104-9. PubMed ID: 1723833
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
Blum WF; Hall K; Ranke MB; Wilton P
Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():15-9. PubMed ID: 7693071
[TBL] [Abstract][Full Text] [Related]
6. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of insulin-like growth factor (IGF)-I treatment on serum IGFs and IGF binding proteins in adolescent patients with growth hormone receptor deficiency.
Wilson KF; Fielder PJ; Guevara-Aguirre J; Cohen P; Vasconez O; Martinez V; Martinez A; Rosenbloom AL; Rosenfeld RG
Clin Endocrinol (Oxf); 1995 Apr; 42(4):399-407. PubMed ID: 7538453
[TBL] [Abstract][Full Text] [Related]
9. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
[TBL] [Abstract][Full Text] [Related]
10. Effects of insulin-like growth factor I treatment on the molecular distribution of insulin-like growth factors among different binding proteins.
Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Diamond FB; Baxter RC; Rosenbloom AL; Guevara-Aguirre J; Rosenfeld RG
Acta Paediatr Suppl; 1994 Apr; 399():159-62. PubMed ID: 7524822
[TBL] [Abstract][Full Text] [Related]
11. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
Bang P; Brismar K; Rosenfeld RG; Hall K
J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
[TBL] [Abstract][Full Text] [Related]
12. Quantification of urinary insulin-like growth factors (IGFs) and IGF binding protein 3 in healthy volunteers before and after stimulation with recombinant human growth hormone.
Tönshoff B; Blum WF; Vickers M; Kurilenko S; Mehls O; Ritz E
Eur J Endocrinol; 1995 Apr; 132(4):433-7. PubMed ID: 7536090
[TBL] [Abstract][Full Text] [Related]
13. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.
Miell JP; Zini M; Quin JD; Jones J; Portioli I; Valcavi R
J Clin Endocrinol Metab; 1994 Nov; 79(5):1507-12. PubMed ID: 7525638
[TBL] [Abstract][Full Text] [Related]
14. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
McCarthy TL; Casinghino S; Centrella M; Canalis E
J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
Young SC; Underwood LE; Celniker A; Clemmons DR
J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
[TBL] [Abstract][Full Text] [Related]
16. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
[TBL] [Abstract][Full Text] [Related]
17. The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis.
Pucilowska JB; Davenport ML; Kabir I; Clemmons DR; Thissen JP; Butler T; Underwood LE
J Clin Endocrinol Metab; 1993 Dec; 77(6):1516-21. PubMed ID: 7505287
[TBL] [Abstract][Full Text] [Related]
18. Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency.
Thorén MC; Wivall-Helleryd IL; Blum WF; Hall KE
Eur J Endocrinol; 1994 Jul; 131(1):33-40. PubMed ID: 7518727
[TBL] [Abstract][Full Text] [Related]
19. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
Gargosky SE; Tapanainen P; Rosenfeld RG
Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
[TBL] [Abstract][Full Text] [Related]
20. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
